Oliver Lagore Vanvalin Investment Group Charles River Laboratories International, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 40 shares of CRL stock, worth $7,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$7,077% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
624Shares Held
54.9MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$900 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$758 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$423 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$405 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...